Migraines & headaches — all decisions

The veteran withdrew his appeal for service connection for a headache disorder before the Board made a decision.

The Board denied service connection for various conditions, including a head injury, headache disorder, erectile dysfunction, left earache disorder, chronic fatigue, right shoulder disorder, irritable bowel syndrome, right foot disorder, GERD, and left shoulder disorder, as the evidence did not support current diagnoses of these conditions.

The Board granted service connection for tension headaches with migraines and obstructive sleep apnea, both as secondary to the Veteran's service-connected major depressive disorder (MDD) with post-traumatic stress disorder (PTSD).

The Board granted a restoration of the separate 10 percent rating for vertigo, an earlier effective date for service connection for vertigo and migraines, and a 30 percent rating for hypothyroidism with heart murmur. The decision also denied an earlier effective date for hypertension and remanded claims for obesity, obstructive sleep apnea, and individual unemployability.

The Board remands the Veteran's claim for service connection for migraines, including as secondary to tinnitus, due to pre-decisional duty-to-assist errors and the need for additional medical opinions.

The Board denied the Veteran's appeal for an initial rating in excess of 30 percent for migraines, finding that his symptoms more closely approximate a 30 percent disability rating.

The Board denied service connection for migraine and muscle tension headaches, including as secondary to bilateral hearing loss, tinnitus, otitis media, and spine arthritis.

The Veteran withdrew her appeal for an increased rating for a headache disability, and the Board dismissed the claim.

The Board denied the veteran's claims for service connection for PTSD, COPD, a gastrointestinal disability, and migraines due to lack of evidence supporting a link between these conditions and her military service.

The Board granted an effective date of May 17, 2019, for a 70 percent disability rating for PTSD but denied earlier effective dates for service connection for bilateral hearing loss and tinnitus.

The appeal concerning the service connection for various conditions and the propriety of a rating reduction has been withdrawn by the Appellant.

The Board remands the claims for service connection for chronic diarrhea, headaches, and neck pain for initial adjudication on the merits by the AOJ.

The Board granted service connection for a bilateral foot condition and migraines, but remanded the claim for a back condition.

The Board remands the claims for service connection for PTSD, diabetes mellitus, type II, migraines, left and right knee disorders, and obstructive sleep apnea due to missing military records and inadequate examinations.

The Board remands the claims for service connection for headaches and an acquired psychiatric disorder due to insufficient evidence.

The Board denied service connection for an acquired psychiatric disorder, chronic rhinitis, and obstructive sleep apnea. The headache claim was remanded for further examination.

The Board granted an initial 50 percent disability rating for the Veteran's service-connected migraine headaches due to very frequent completely prostrating and prolonged attacks capable of producing severe economic inadaptability.

The Board denied service connection for various disabilities, including an acquired psychiatric disability, headaches, a back disability, heart disability, and residuals of a stroke, as the evidence did not support a finding that these conditions were related to the Veteran's active service or caused by his service-connected left ear disabilities.

The appeal for service connection for hypothyroidism and migraines was dismissed due to the Veteran's withdrawal of the appeal. The appeals for right and left wrist disabilities are remanded for further development.

The Board remands the claim for a VA examination to clarify the severity of the Veteran's headaches without considering the effects of pain-relieving medication.